G. Romey et al., EFFECTS OF 2 CHEMICALLY RELATED NEW CA2-TYPE CARDIAC CHANNEL( CHANNELANTAGONISTS, SR33557 (FANTOFARONE) AND SR33805, ON THE L), European journal of pharmacology, 263(1-2), 1994, pp. 101-105
Fantofarone (SR33557) is a substituted indolizine and SR33805 is a sub
stituted indole. These drugs have been shown to specifically bind to t
he alpha(1) subunit of the L-type Ca2+ channel at the same site, disti
nct from those of the classical 1,4-dihydropyridine, phenylalkylamine
or benzothiazepine Ca2+ antagonists, but in negative allosteric intera
ction with them. The present work shows that fantofarone and SR33805 b
lock L-type but not T-type Ca2+ channels in mouse cardiac cells in pri
mary culture. This block is voltage-dependent. Fantofarone and SR33805
are potent Ca2+ channel blockers in depolarized conditions (i.e. at a
holding potential of -40 mV) with an EC(50) = 1.4 and 4.1 nM, respect
ively. In polarized conditions (i.e. at a holding potential of -80 mV)
, SR33805 is a better Ca2+ channel blocker (EC(50) = 33 nM) than fanto
farone (EC(50) = 0.15 mu M). Therefore differences in their chemical s
tructures make the blacking action of fantofarone more sensitive to vo
ltage than that of SR33805.